# VENTURI (VENTilation Using Respiratory Imaging)

> **NCT07282886** · PHASE2 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 20 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI
- **DRUG:** Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation Powder

## Key facts

- **NCT ID:** NCT07282886
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282886, "VENTURI (VENTilation Using Respiratory Imaging)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07282886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*